Evidence map›Paper›PMID 39619817›Full record

Review3 Biotech2024

Leveraging bacterial laccases to facilitate the decomposition of xenobiotic compounds: a review.

Kalyanee Bera, Debalina Bhattacharya, Mainak Mukhopadhyay

Abstract readReview
In one paragraph

Review in 3 Biotech, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kalyanee BeraDepartment of Biosciences, JIS University, Agarpara, Kolkata, 700109 India.
Debalina BhattacharyaDepartment of Microbiology, Maulana Azad College, Kolkata, 700013 West Bengal India.
Mainak MukhopadhyayDepartment of Biosciences, JIS University, Agarpara, Kolkata, 700109 India.ORCID 0000-0001-9224-3963

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xenobiotic compounds are artificial substances that are essential in our lives. These substances have a negative impact on the environment because they are long-lasting and biodegrade slowly or not at all in ecosystems. When xenobiotics leak into the ecosystem, they enter the food chain and negatively impact animals' and people's health across all trophic levels. Moreover, these pollutants have toxic, mutagenic, carcinogenic, and teratogenic effects on all living organisms. They can affect humans in ways such as brain and prostate gland abnormalities, abnormalities of children's behavior, skin disorders, liver issues, immune system impairment, and endocrine system distribution. Consequently, it is essential to remove harmful, non-biodegradable xenobiotics from the ecosystem. Degradation of these chemicals hence requires immediate attention and awareness. The physical-chemical methods for removing the pollutants are costly. Bioremediation is a concept that uses organisms to control the environment faster and with less labor. Bacterial laccase-mediated bioremediation offers inexpensive, environmentaly sustainable, and potential degradation mechanisms for different recalcitrant chemicals. At the high temperature, high pH, contact time, and concentration, bacterial laccase can degrade the xenobiotic compounds. After degradation, convert them into low-toxic, non-hazardous substances in the environment by oxidation, reduction, elimination, and ring-opening processes. The aspects of this review article are bacterial laccase-mediated xenobiotic compound degradation.

Indexed as

Advanced technologiesApplicationsBacterial laccaseBiodegradationImmobilizationXenobiotic compounds

Identifiers

PMID39619817
PMCPMC11604876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.